CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-13 | FMR LLC 10% owner | Conversion | +2,507,971 | 2,507,971 | ||
| 2015-10-13 | FMR LLC 10% owner | Conversion | +527,009 | 3,034,980 | ||
| 2015-10-13 | FMR LLC 10% owner | Conversion | +433,844 | 3,468,824 | ||
| 2015-10-13 | FMR LLC 10% owner | Purchase | +335,455 | $11.00 | $3.7M | 3,804,279 |
| 2015-10-13 | FMR LLC 10% owner | Conversion · Series A Convertible Preferred Stock | +8,652,500 | 0 | ||
| 2015-10-13 | FMR LLC 10% owner | Conversion · Series B Convertible Preferred Stock | +1,818,182 | 0 | ||
| 2015-10-13 | FMR LLC 10% owner | Conversion · Series C Convertible Preferred Stock | +1,496,764 | 0 | ||
| 2015-10-13 | CHA ALBERT Director | Conversion | +3,433,646 | 3,736,852 | ||
| 2015-10-13 | CHA ALBERT Director | Purchase | +454,545 | $11.00 | $5.0M | 4,191,397 |
| 2015-10-13 | CHA ALBERT Director | Conversion · Series A Preferred Stock | −8,652,500 | 0 | ||
| 2015-10-13 | CHA ALBERT Director | Conversion · Series B Preferred Stock | −1,818,182 | 0 | ||
| 2015-10-13 | CHA ALBERT Director | Conversion · Series C Preferred Stock | −1,375,405 | 0 | ||
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Conversion | +3,360,408 | 3,657,147 | ||
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Purchase | +444,850 | $11.00 | $4.9M | 4,101,997 |
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Conversion | +73,238 | 79,705 | ||
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Purchase | +9,695 | $11.00 | $107K | 89,400 |
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Conversion · Series A Preferred Stock | −8,467,943 | 0 | ||
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Conversion · Series A Preferred Stock | −184,557 | 0 | ||
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Conversion · Series B Preferred Stock | −1,779,400 | 0 | ||
| 2015-10-13 | VIVO VENTURES VII, LLC 10% owner | Conversion · Series B Preferred Stock | −38,782 | 0 |
Page 55 of 57 · 1,130 trades